Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model |
| |
Authors: | Iyer Radhakrishnan P Roland Arlene Jin Yi Mounir Samir Korba Brent Julander Justin G Morrey John D |
| |
Affiliation: | Origenix Techonologies, Inc., St. Laurent, Quebec, Canada. |
| |
Abstract: | ORI-9020, a novel dinucleotide, evaluated in transgenic mice expressing hepatitis B virus (HBV), significantly reduced liver HBV DNA (P = 0.001). Levels of HBeAg and HBsAg in serum and of HBcAg in liver were not affected by treatment. A minimal effective dosage was determined to be between 1.6 and 0.5 mg/kg of body weight/day, which was similar to that observed for adefovir dipivoxil. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|